Anti-leishmanial activity of Brevinin 2R and its Lauric acid conjugate type against L. major: In vitro mechanism of actions and in vivo treatment potentials.
Leishmaniasis, as a major health problem in tropical and sub-tropical areas in the world, needs novel, safe, nontoxic and plausible therapeutic solutions for its control. As a part of innate immune system, natural antimicrobial peptides have a potential to be used as new generation of antibiotics es...
Main Authors: | Farnaz Zahedifard, Hyeryon Lee, Joo Hwan No, Mona Salimi, Negar Seyed, Ahmad Asoodeh, Sima Rafati |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-02-01
|
Series: | PLoS Neglected Tropical Diseases |
Online Access: | http://europepmc.org/articles/PMC6411200?pdf=render |
Similar Items
-
Correction: Anti-leishmanial activity of Brevinin 2R and its Lauric acid conjugate type against L. major: In vitro mechanism of actions and in vivo treatment potentials.
by: Farnaz Zahedifard, et al.
Published: (2019-07-01) -
Human neutrophil peptide-1 (HNP-1): a new anti-leishmanial drug candidate.
by: Sara Dabirian, et al.
Published: (2013-01-01) -
Brevinin-2R-linked polyethylenimine as a promising hybrid nano-gene-delivery vector
by: Fatemeh Zohrab, et al.
Published: (2019-09-01) -
Leishmanial abscess
by: Sandeep Arora, et al.
Published: (2017-01-01) -
Evaluation of leishmanicidal effect of Euphorbia petiolata extract by in vivo anti-leishmanial assay using promastigotes of Leishmania major
by: Reza Kazemi Oskuee, et al.
Published: (2018-11-01)